Teva Pharmaceutical Industries

Historical 13F Holders

Symbol
TEVA
CUSIP
881624209
All holders as of
Q3 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 881624209 since 12/18/2024, newest first.

Filer % of Class Filed
Menora Mivtachim Holdings Ltd. 13G/A Amendment 1 4.99% 11/10/2026
Event 11/5/2026
Migdal Insurance & Financial Holdings Ltd. 13G 5.4% 2/17/2026
Event 12/31/2025
Phoenix Financial Ltd. 13G 5.0% 7/22/2025
Event 7/14/2025
Menora Mivtachim Holdings Ltd 13G 5.0% 7/17/2025
Event 7/16/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 24 97.7 M $3.88B
2026 Q2 685 734 M $24.7B
2026 Q1 664 674 M $20.2B
2025 Q4 654 687 M $21.4B
2025 Q3 572 692 M $14.0B
2025 Q2 554 721 M $11.9B
2025 Q1 574 714 M $11.0B
2024 Q4 598 666 M $14.6B
2024 Q3 554 636 M $11.2B
2024 Q2 538 608 M $9.88B
2024 Q1 491 571 M $8.05B
2023 Q4 451 578 M $6.07B
2023 Q3 439 555 M $5.66B
2023 Q2 433 499 M $3.77B
2023 Q1 441 560 M $4.95B
2022 Q4 427 561 M $5.12B
2022 Q3 437 560 M $4.55B
2022 Q2 462 507 M $3.85B
2022 Q1 443 515 M $4.89B
2021 Q4 454 521 M $4.19B
2021 Q3 438 527 M $5.19B
2021 Q2 449 561 M $5.61B
2021 Q1 461 575 M $6.85B
2020 Q4 462 573 M $5.63B
2020 Q3 456 563 M $5.16B
2020 Q2 465 580 M $7.26B
2020 Q1 469 555 M $5.07B
2019 Q4 451 588 M $5.77B
2019 Q3 443 594 M $4.08B
2019 Q2 462 645 M $5.96B
2019 Q1 531 674 M $10.6B
2018 Q4 565 687 M $10.6B
2018 Q3 573 642 M $13.8B
2018 Q2 563 673 M $16.4B
2018 Q1 528 673 M $11.5B
2017 Q4 531 594 M $11.2B
2017 Q3 556 540 M $9.50B
2017 Q2 667 591 M $19.6B
2017 Q1 702 579 M $18.6B
2016 Q4 753 603 M $21.9B
2016 Q3 803 569 M $26.2B
2016 Q2 827 596 M $29.9B
2016 Q1 849 600 M $32.1B
2015 Q4 887 612 M $40.2B
2015 Q3 829 528 M $29.8B
2015 Q2 826 516 M $30.5B
2015 Q1 836 522 M $32.5B
2014 Q4 830 518 M $29.8B
2014 Q3 779 500 M $26.9B
2014 Q2 790 487 M $25.7B
2014 Q1 781 474 M $25.0B